loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2002_211___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    HUASHU PHARMACEUTICAL CORPORATION

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Huashu Pharmaceutical Corporation Shijiazhuang CN (1)

    filter

    01 Oxytetracycline dihydrate (1)

    filter

    01 China (1)

    filter

    01 Withdrawn by EDQM Failure to CEP procedure (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Huashu Pharmaceutical Corporation S...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Oxytetracycline dihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2002-211 - Rev 00
    Withdrawn by EDQM F...
    Chemical
    2012-10-26
    2017-03-20
    199
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-211 - Rev 00 of Huashu Pharmaceutical Corporation Shijiazhuang Cn

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-211 - Rev 00 of Huashu Pharmaceutical Corporation Shijiazhuang Cn 1

    20

    Huashu Pharmaceutical Corporation Shijiazhuang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Oxytetracycline dihydrate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2002-211 - Rev 00

    This Chemical Type CEP, issued on October 26, 2012, remains in force until March 20, 2017, ensuring its reliability within the pharmaceutical industry.

    Substance Number 199 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY